Question 1

Purpose Test

Accepted Answer

Diagnosing immune hemolytic anemia, whether primary (autoimmune disease) or secondary (caused by drugs, other diseases, or cancer). Investigating unexplained hemolytic anemia, especially when symptoms like jaundice and unexplained indirect bilirubin elevation are present. Detecting hemolytic transfusion reactions, where recipient antibodies recognize and attack transfused red blood cells. Diagnosing hemolytic disease of the newborn (HDN) caused by blood group incompatibility between mother and fetus (e.g., Rh or ABO incompatibility).

Question 2

Recommended groups

Accepted Answer

Newborn infants with severe or early jaundice, suspected of blood incompatibility with the mother. Patients with hemolytic anemia symptoms (pallor, jaundice, fatigue) without a clear cause. Patients showing symptoms after blood transfusion (fever, chills, dark urine). Patients diagnosed with diseases associated with immune hemolytic anemia (e.g., lupus, lymphoma, chronic lymphocytic leukemia CLL). Patients taking drugs known to cause drug-induced hemolytic anemia.

Question 3

Symptoms indicative

Accepted Answer

Severe pallor and unexplained fatigue. Yellowing of the eyes and skin (jaundice). Dark-colored urine (tea-colored or cola-colored). Fever or back pain after a recent blood transfusion. Enlarged spleen.

Question 4

Frequently Asked Questions (FAQs)

Accepted Answer

Direct (DAT): Detects antibodies actually attached to the patient’s red blood cells in the body. It answers the question: "Is your immune system attacking your red blood cells?" Indirect (IAT): Detects free antibodies in the patient’s serum that could attack foreign red blood cells (e.g., transfused blood). It is used before transfusion to ensure compatibility. After a recent blood transfusion. After certain medications (e.g., some antibiotics). In some diseases that cause nonspecific protein binding to red blood cells. These positive results are often “weak” and not associated with clinical symptoms.

Question 5

Normal Levels

Accepted Answer

The normal result is negative, meaning no agglutination of red blood cells occurs after adding anti-human serum. This indicates that no IgG antibodies or complement components (C3d) are abnormally attached to the red blood cells. A positive result is usually reported with the reaction strength (weak, moderate, strong) and the type of coating (IgG only, C3d only, or both), which helps in determining the underlying cause.

Direct Coombs Test